Sun Forwards Specialty Strategy With $576m Concert Acquisition
Sun’s Nabs Concert, Picking Up Firm’s ‘Potential Best-In-Class’ Deuruxolitinib
• By Rosalind Rei
Sun Pharma's Concert Acquisition Will Further Bolster Its Specialty Portfolio • Source: Shutterstock 
